Open-Label Extension Study for Patients Who Completed a Phase 3 Double-blind Study of PEG-uricase for Symptomatic Gout
Clinical trial NCT01356498 · COMPLETED
Trial details
- NCT number
- NCT01356498
- Sponsor
- Savient Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2010-01-01
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.